Zespół Zakładów Opieki Zdrowotnej W Cieszynie
Cieszyn, Poland
Treatment & access
- Treatments offeredesketamine (Spravato)
- Access routepublic_reimbursed
- Price informationCovered by NFZ (drug programme B.147)
- ReimbursementNFZ drug programme B.147 - leczenie chorych na depresję lekooporną How reimbursement works in Europe →
- Phone+48 33 854 92 00
- Websitehttps://www.szpitalslaski.pl/
About this provider
Zespół Zakładów Opieki Zdrowotnej w Cieszynie operates Szpital Śląski, the multi-specialty district hospital in Cieszyn (ul. Bielska 4). Per NFZ data it runs program B.147 — fully funded esketamine (Spravato) for treatment-resistant depression — with no queue reported as of June 2026; the program contact points are its Psychiatric Ward and Day Psychiatric Ward. Its own site describes an adult Mental Health Center (CZP) offering support in emotional crises without prior appointment, a community treatment team, mental health outpatient clinics, and a day psychiatric rehabilitation ward for adolescents.
Services & programs
- Adult Mental Health Center (CZP) — support in emotional crises without prior appointment
- Psychiatric Ward (general)
- Day Psychiatric Ward (general)
- Community treatment team (within the CZP)
- Mental health outpatient clinics, including a clinic for children and adolescents
- Day psychiatric rehabilitation ward for adolescents (since 2024)
Common questions
How do I start esketamine treatment in Cieszyn?
Contact the hospital — registration +48 33 852 05 11 or the switchboard +48 33 854 92 00. Qualification for NFZ program B.147 is done by the center's psychiatrists: adults 18-75 with moderate-to-severe depression that has not responded to at least two antidepressants.
Do I need a referral?
A doctor's referral is the standard route into the program, but the hospital's adult Mental Health Center states it provides psychiatric help without prior appointment, which can be the first step to assessment.
Is anything paid out of pocket?
No — program B.147 is fully NFZ-funded for insured patients, covering the esketamine nasal spray sessions supervised at the center for up to 34 weeks.
Verification
- License / registryNFZ B.147
- Sourcehttps://api.nfz.gov.pl/app-itl-api/queues?case=1&benefit=LECZENIE%20CHORYCH%20NA%20DEPRESJ%C4%98%20LEKOOPORN%C4%84
- Last verified